CAXTON CORP 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:15 pm Sale |
2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
CAXTON CORP | 5,973,324 4.400% |
-1,856,358 (-23.71%) |
Filing |
| 2022-01-05 12:38 pm Purchase |
2021-10-05 | 13G | Xeris Biopharma Holdings, Inc. XERS |
CAXTON CORP | 7,829,682 5.700% |
7,829,682 (New Position) |
Filing |